JP2002514404A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002514404A5 JP2002514404A5 JP2000548371A JP2000548371A JP2002514404A5 JP 2002514404 A5 JP2002514404 A5 JP 2002514404A5 JP 2000548371 A JP2000548371 A JP 2000548371A JP 2000548371 A JP2000548371 A JP 2000548371A JP 2002514404 A5 JP2002514404 A5 JP 2002514404A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- composition
- conjugated
- patient
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP3450A AUPP345098A0 (en) | 1998-05-11 | 1998-05-11 | Novel anti-fibrinolytic agents |
| AU3450 | 1998-05-11 | ||
| PCT/AU1999/000343 WO1999058569A1 (en) | 1998-05-11 | 1999-05-07 | PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002514404A JP2002514404A (ja) | 2002-05-21 |
| JP2002514404A5 true JP2002514404A5 (cg-RX-API-DMAC7.html) | 2006-07-13 |
| JP4542705B2 JP4542705B2 (ja) | 2010-09-15 |
Family
ID=3807704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548371A Expired - Fee Related JP4542705B2 (ja) | 1998-05-11 | 1999-05-07 | オーストラリア・ブラウン・スネーク，プソイドナジャ・テキスティリス・テキスティリスからのプラスミンインヒビター |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7070969B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1078003B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4542705B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE440108T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AUPP345098A0 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2328431C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69941292D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1078003T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2332249T3 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ508770A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999058569A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP345098A0 (en) * | 1998-05-11 | 1998-06-04 | National Institute Of Biological Standards And Control, United Kingdom | Novel anti-fibrinolytic agents |
| US6506365B1 (en) * | 2000-09-25 | 2003-01-14 | Baxter Aktiengesellschaft | Fibrin/fibrinogen binding conjugate |
| US7745192B2 (en) * | 2002-04-03 | 2010-06-29 | Venomics Pty Limited | Prothrombin activating protein |
| ES2431526T3 (es) | 2005-12-29 | 2013-11-26 | The Regents Of The University Of California Office Of Technology Transfer | Procedimientos y composiciones relacionadas con el dominio Kunitz I mutante de TFPI-2 |
| EP2154152A1 (en) * | 2008-08-08 | 2010-02-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Use of Conkunitzin-S1 for the modulation of glucose-induced insulin secretion |
| US20110287036A1 (en) * | 2008-11-17 | 2011-11-24 | Riken | Novel cancer targeting therapy using complex of subtance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound |
| CN102850451B (zh) * | 2011-06-29 | 2014-05-07 | 辽宁诺康生物制药有限责任公司 | 具有抑制纤溶酶活性的重组textilinin-1及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5342830A (en) * | 1990-11-16 | 1994-08-30 | Cor Therapeutics, Inc. | Antithrombosis agents |
| EP0585504A1 (en) * | 1992-09-04 | 1994-03-09 | Pentapharm A.G. | Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing |
| AUPP076797A0 (en) * | 1997-12-05 | 1998-01-08 | Active (Pla) R&D Pty Ltd | Phospholipase inhibitor |
| AUPP345098A0 (en) * | 1998-05-11 | 1998-06-04 | National Institute Of Biological Standards And Control, United Kingdom | Novel anti-fibrinolytic agents |
-
1998
- 1998-05-11 AU AUPP3450A patent/AUPP345098A0/en not_active Abandoned
-
1999
- 1999-05-07 NZ NZ508770A patent/NZ508770A/en unknown
- 1999-05-07 ES ES99918966T patent/ES2332249T3/es not_active Expired - Lifetime
- 1999-05-07 DE DE69941292T patent/DE69941292D1/de not_active Expired - Lifetime
- 1999-05-07 JP JP2000548371A patent/JP4542705B2/ja not_active Expired - Fee Related
- 1999-05-07 EP EP99918966A patent/EP1078003B1/en not_active Expired - Lifetime
- 1999-05-07 DK DK99918966T patent/DK1078003T3/da active
- 1999-05-07 AT AT99918966T patent/ATE440108T1/de not_active IP Right Cessation
- 1999-05-07 CA CA2328431A patent/CA2328431C/en not_active Expired - Fee Related
- 1999-05-07 US US09/700,179 patent/US7070969B1/en not_active Expired - Lifetime
- 1999-05-07 WO PCT/AU1999/000343 patent/WO1999058569A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005081711A3 (en) | Monomethylvaline compounds capable of conjugation to ligands | |
| CA2267456A1 (en) | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same | |
| MY129356A (en) | Electrospun pharmaceutical compositions | |
| JP2001522783A5 (cg-RX-API-DMAC7.html) | ||
| CA2360248A1 (en) | Combinations of formoterol and a tiotropium salt | |
| BR0014652A (pt) | Fabricação de conjugados de agente terapêutico-poliglutamato | |
| NO20015584L (no) | Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling | |
| WO1998001158A3 (de) | Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel | |
| AU2001282267A1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
| PT1214077E (pt) | Libertacao local de estradiol 17-beta para melhorar a funcao vascular do endotelio na sequencia de feridas vasculares | |
| NO20012716L (no) | Terapeutisk middel for undertrykkelse av snorkelyder | |
| WO1999044608A8 (en) | New use | |
| BR9815562A (pt) | Processo de preparação de nanocápsulas, suspenção coloidal de nanocápsulas e composição terapêutica | |
| JP2002542248A5 (cg-RX-API-DMAC7.html) | ||
| JP2002522501A5 (cg-RX-API-DMAC7.html) | ||
| WO2001060412A3 (en) | Modification of biopolymers for improved drug delivery | |
| JP2002514404A5 (cg-RX-API-DMAC7.html) | ||
| JP2001513504A5 (cg-RX-API-DMAC7.html) | ||
| JP2004500325A5 (cg-RX-API-DMAC7.html) | ||
| CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
| WO2003037272A3 (en) | Thymosin alpha 1 peptide/polymer conjugates | |
| CA2337667A1 (en) | Dextran-leptin conjugates, pharmaceutical compositions and related methods | |
| CA2373252A1 (en) | Long lasting anti-angiogenic peptides | |
| MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
| JP2002500181A5 (cg-RX-API-DMAC7.html) |